Strategic Wealth Investment Group’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-31,530
Closed -$47.3K 135
2023
Q1
$47.3K Hold
31,530
0.01% 129
2022
Q4
$45.7K Sell
31,530
-5,478
-15% -$6.9K 0.01% 119
2022
Q3
$42K Sell
37,008
-12,728
-26% -$18.7K 0.01% 110
2022
Q2
$79K Sell
49,736
-12,752
-20% -$16.8K 0.02% 130
2022
Q1
$96K Sell
62,488
-2,581
-4% -$4K 0.02% 99
2021
Q4
$159K Sell
65,069
-5,556
-8% -$13K 0.04% 84
2021
Q3
$179K Buy
70,625
+6,393
+10% +$16.4K 0.05% 81
2021
Q2
$183K Sell
64,232
-382
-0.6% -$988 0.06% 82
2021
Q1
$152K Sell
64,614
-2,303
-3% -$5.53K 0.07% 72
2020
Q4
$118K Sell
66,917
-2,957
-4% -$4.13K 0.07% 76
2020
Q3
$65K Buy
69,874
+10,277
+17% +$9.08K 0.05% 82
2020
Q2
$52K Buy
+59,597
New +$52.5K 0.05% 78

Other funds holding LCTX